NCT06764251 2025-01-08
Tislelizumab Combined with SOX Regimen in the Treatment of Locally Advanced Gastric Cancer/gastroesophageal Junction Adenocarcinoma
Liaoning Cancer Hospital & Institute
Phase 2 Not yet recruiting
Clinical Trials
1 trialsNot yet recruiting × Gastric/Gastroesophageal Junction Adenocarcinoma × Gastrointestinal × Clear all